An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine

Raman L Mitra; Steven A Greenstein; Laurence M Epstein

doi:10.1016/j.hrcr.2020.03.016

An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine

HeartRhythm Case Rep. 2020 Apr 1;6(5):244-248. doi: 10.1016/j.hrcr.2020.03.016. eCollection 2020 May.

Authors

Raman L Mitra¹, Steven A Greenstein¹, Laurence M Epstein¹

Affiliation

¹ Northshore University Hospital, Northwell Health, Manhasset, New York.

No abstract available

Keywords: Acquired LQTS; Azithromycin; COVID-19; Chloroquine; Drug toxicity; Flow chart; Hydroxychloroquine; Long QT; Pandemic; Proarrhythmia; Torsades de pointes; Ventricular fibrillation.

Publication types

Case Reports